Hypofractionated high-dose intensity-modulated radiotherapy

From WikiMD's WELLNESSPEDIA

This is an experimental form of intensity-modulated radiotherapy where higher X-ray dosages are used in fewer fractions (sessions) this is called hypofractionated radiotherapy. Although the dose per fraction is higher than standard radiotherapy, the total dose is lower.[1]

The hope is that it will be as effective but cause less toxicity.[1]

Prostate cancer[edit]

One trial[2] for prostate cancer ran in 2011.[1]In 2016 the HYPRO study reported results comparing the use of standard fractionation (39 fractions of 2 Gy for 8 weeks) with hypofractionation (with 19 fractions of 3.4 Gy for 6.5 weeks) among 820 patients with intermediate- or high-risk prostate cancer.[3]

References[edit]

  1. ↑ 1.0 1.1 1.2 A trial comparing different ways of giving radiotherapy for prostate cancer (CHHIP)(link). {{{website}}}. 2015-03-17.
  2. ↑ UKCRN Database:Conventional or Hypofractionated High Dose Intensity Modulated Radiotherapy for Prostate Cancer Archived September 27, 2007, at the Wayback Machine
  3. ↑ Toxicities May Affect Readiness of Hypofractionation in Prostate Cancer. March 2016


Stub icon

This oncology article is a stub. You can help WikiMD by expanding the page.

Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Hypofractionated_high-dose_intensity-modulated_radiotherapy&oldid=6509369"